Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Anti-Cancer Drugs
|
April 1, 1992
Cytotoxic effects and pharmacokinetic analysis of combined adriamycin and X-ray treatments in human organotypic cell cultures
S Chevillard, P Vielh, F Campana, et al.
Anticancer Research
|
November 1, 1994
Binding of anthracycline derivatives to human serum lipoproteins
O Chassany, S Urien, P Claudepierre, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Comparative serum protein binding of anthracycline derivatives
O Chassany, S Urien, P Claudepierre, et al.
Investigational New Drugs
|
January 1, 1995
Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes
S Urien, P Nguyen, G Bastian, et al.
Anticancer Research
|
December 31, 1997
Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line
F Bichat, R Mouawad, G Solis-Recendez, et al.
Oncology (Williston Park, N.Y.)
|
May 12, 2001
The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer
D Khayat, M Gil-Delgado, E C Antoine, et al.
Cellular Immunology
|
July 27, 2020
Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3<sup>+</sup> regulatory T cells
Mark D Mannie, Kayla B DeOca, Alexander G Bastian, et al.
Investigational New Drugs
|
November 1, 1992
Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique
S Urien, G Bastian, C Lucas, et al.
Viruses
|
May 28, 2025
A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity
Hoda H Jabbour, Alexander G Bastian, Kayla B DeOca, et al.
Journal of Neuroinflammation
|
June 12, 2020
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4<sup>+</sup> CD25<sup>+</sup> FOXP3<sup>+</sup> Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)
Cody D Moorman, Alexander G Bastian, Kayla B DeOca, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Anti-Cancer Drugs
|
April 1, 1992
Cytotoxic effects and pharmacokinetic analysis of combined adriamycin and X-ray treatments in human organotypic cell cultures
S Chevillard, P Vielh, F Campana, et al.
Anticancer Research
|
November 1, 1994
Binding of anthracycline derivatives to human serum lipoproteins
O Chassany, S Urien, P Claudepierre, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Comparative serum protein binding of anthracycline derivatives
O Chassany, S Urien, P Claudepierre, et al.
Investigational New Drugs
|
January 1, 1995
Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes
S Urien, P Nguyen, G Bastian, et al.
Anticancer Research
|
December 31, 1997
Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line
F Bichat, R Mouawad, G Solis-Recendez, et al.
Oncology (Williston Park, N.Y.)
|
May 12, 2001
The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer
D Khayat, M Gil-Delgado, E C Antoine, et al.
Cellular Immunology
|
July 27, 2020
Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3<sup>+</sup> regulatory T cells
Mark D Mannie, Kayla B DeOca, Alexander G Bastian, et al.
Investigational New Drugs
|
November 1, 1992
Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique
S Urien, G Bastian, C Lucas, et al.
Viruses
|
May 28, 2025
A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity
Hoda H Jabbour, Alexander G Bastian, Kayla B DeOca, et al.
Journal of Neuroinflammation
|
June 12, 2020
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4<sup>+</sup> CD25<sup>+</sup> FOXP3<sup>+</sup> Tregs that inhibit experimental autoimmune encephalomyelitis (EAE)
Cody D Moorman, Alexander G Bastian, Kayla B DeOca, et al.
Page
of 5